February 6, 2019

Improving Alzheimer’s Disease Management: Early Diagnosis and Health Equity Considerations

Hybrid 2021 Alzheimer’s Association International Conference (AAIC)

Welcome and Introduction

Panel chair Marwan Sabbagh, MD, introduces the symposium before providing an overview of health equity and an outline of current healthcare disparities in AD.

Key Learning Objectives from Biogen’s AAIC 2021 Symposium:

  • Highlight the importance of early detection and diagnosis of AD, through appropriate use of cognitive and functional screening tools and biomarker assessments
  • Assess current healthcare system readiness for a paradigm shift to early diagnosis of AD
  • Outline considerations in patient care for underrepresented and underserved populations

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.